Epicardial Steatosis, Insulin Resistance, and Coronary Artery Disease

Heart Failure Clinics

Volumn 8, Issue 4, 2012, Pages 671-678

  Toth, Peter P ^a,b  

^a CGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Adipose tissue; Coronary artery disease; Epicardium; Fatty acid; Inflammation; Insulin resistance; Metabolic syndrome

Indexed keywords

ADIPONECTIN; CYTOKINE; FATTY ACID BINDING PROTEIN 4; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; RESISTIN; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL OBESITY; ARRHYTHMOGENESIS; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CORONARY FLOW RESERVE; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; EPICARDIUM; FATTY LIVER; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; LIPOPROTEIN METABOLISM; METABOLIC STRESS; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXIDATIVE PHOSPHORYLATION; PARACRINE SIGNALING; PROTEIN PHOSPHORYLATION; REVIEW; SENSITIVITY AND SPECIFICITY; SMOKING; STEATOSIS; WEIGHT REDUCTION;

ADIPOSE TISSUE; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; FATTY ACIDS; HEART; HEART DISEASES; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME X; PERICARDIUM; RISK;

EID: 84866624214     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2012.06.013     Document Type: Review

References (53)

1. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285(19):2486-2497.
2. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288(21):2709-2716.
3. Fujimoto W.Y., Abbate S.L., Kahn S.E., et al. The visceral adiposity syndrome in Japanese-American men. Obes Res 1994, 2(4):364-371.
4. Lamarche B., Tchernof A., Mauriege P., et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 1998, 279(24):1955-1961.
5. Oresic M. Systems biology strategy to study lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 2010, 1801(3):235-239.
6. Virtue S., Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the metabolic syndrome-an allostatic perspective. Biochim Biophys Acta 2010, 1801(3):338-349.
7. Leto D., Saltiel A.R. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 2012, 13(6):383-396.
8. Erion D.M., Shulman G.I. Diacylglycerol-mediated insulin resistance. Nat Med 2010, 16(4):400-402.
9. Ukkola O., Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities?. J Mol Med (Berl) 2002, 80(11):696-702.
10. Myers M.G., Cowley M.A., Munzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 2008, 70:537-556.
11. Steppan C.M., Bailey S.T., Bhat S., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409(6818):307-312.
12. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444(7121):840-846.
13. Franssila-Kallunki A., Rissanen A., Ekstrand A., et al. Effects of weight loss on substrate oxidation, energy expenditure, and insulin sensitivity in obese individuals. Am J Clin Nutr 1992, 55(2):356-361.
14. DeFronzo R.A., Sherwin R.S., Kraemer N. Effect of physical training on insulin action in obesity. Diabetes 1987, 36(12):1379-1385.
15. Kim M.K., Tomita T., Kim M.J., et al. Aerobic exercise training reduces epicardial fat in obese men. J Appl Physiol 2009, 106(1):5-11.
16. Bosy-Westphal A., Kossel E., Goele K., et al. Association of pericardial fat with liver fat and insulin sensitivity after diet-induced weight loss in overweight women. Obesity (Silver Spring) 2010, 18(11):2111-2117.
17. Zhang Y., McGillicuddy F.C., Hinkle C.C., et al. Adipocyte modulation of high-density lipoprotein cholesterol. Circulation 2010, 121(11):1347-1355.
18. Toth P.P. Reverse cholesterol transport: high-density lipoprotein's magnificent mile. Curr Atheroscler Rep 2003, 5(5):386-393.
19. Toth P.P. Adiponectin and high-density lipoprotein: a metabolic association through thick and thin. Eur Heart J 2005, 26(16):1579-1581.
20. Naka Y., Bucciarelli L.G., Wendt T., et al. RAGE axis: animal models and novel insights into the vascular complications of diabetes. Arterioscler Thromb Vasc Biol 2004, 24(8):1342-1349.
21. Toth P.P. Pleiotropic effects of angiotensin receptor blockers: addressing comorbidities by optimizing hypertension therapy. J Clin Hypertens (Greenwich) 2011, 13(1):42-51.
22. Iacobellis G. Epicardial and pericardial fat: close, but very different. Obesity (Silver Spring) 2009, 17(4):625. [author reply: 626-27].
23. Iacobellis G., Sharma A.M. Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome. Curr Pharm Des 2007, 13(21):2180-2184.
24. Rabkin S.W. Epicardial fat: properties, function and relationship to obesity. Obes Rev 2007, 8(3):253-261.
25. Glagov S., Bassiouny H.S., Giddens D.P., et al. Pathobiology of plaque modeling and complication. Surg Clin North Am 1995, 75(4):545-556.
26. Wang T.D., Lee W.J., Shih F.Y., et al. Relations of epicardial adipose tissue measured by multidetector computed tomography to components of the metabolic syndrome are region-specific and independent of anthropometric indexes and intraabdominal visceral fat. J Clin Endocrinol Metab 2009, 94(2):662-669.
27. Greif M., Becker A., von Ziegler F., et al. Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2009, 29(5):781-786.
28. Dey D., Wong N.D., Tamarappoo B., et al. Computer-aided non-contrast CT-based quantification of pericardial and thoracic fat and their associations with coronary calcium and metabolic syndrome. Atherosclerosis 2010, 209(1):136-141.
29. de Vos A.M., Prokop M., Roos C.J., et al. Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J 2008, 29(6):777-783.
30. Rosito G.A., Massaro J.M., Hoffmann U., et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008, 117(5):605-613.
31. Jain S.H., Massaro J.M., Hoffmann U., et al. Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study. Diabetes Care 2009, 32(5):903-908.
32. Iacobellis G., Ribaudo M.C., Assael F., et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003, 88(11):5163-5168.
33. Momesso D.P., Bussade I., Epifanio M.A., et al. Increased epicardial adipose tissue in type 1 diabetes is associated with central obesity and metabolic syndrome. Diabetes Res Clin Pract 2011, 91(1):47-53.
34. Hizli S., Ozdemir O., Abaci A., et al. Relation of subepicardial adipose tissue thickness and clinical and metabolic parameters in obese prepubertal children. Pediatric Diabetes 2010, 11(8):556-562.
35. Sarin S., Wenger C., Marwaha A., et al. Clinical significance of epicardial fat measured using cardiac multislice computed tomography. Am J Cardiol 2008, 102(6):767-771.
36. Park J.S., Ahn S.G., Hwang J.W., et al. Impact of body mass index on the relationship of epicardial adipose tissue to metabolic syndrome and coronary artery disease in an Asian population. Cardiovasc Diabetol 2010, 9:29.
37. Wang C.P., Hsu H.L., Hung W.C., et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol 2009, 70(6):876-882.
38. Ahn S.G., Lim H.S., Joe D.Y., et al. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart 2008, 94(3):e7.
39. Liu J., Fox C.S., Hickson D., et al. Pericardial adipose tissue, atherosclerosis, and cardiovascular disease risk factors: the Jackson heart study. Diabetes Care 2010, 33(7):1635-1639.
40. Crouse J.R., Raichlen J.S., Riley W.A., et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. JAMA 2007, 297(12):1344-1353.
41. Iacobellis G., Sharma A.M., Pellicelli A.M., et al. Epicardial adipose tissue is related to carotid intima-media thickness and visceral adiposity in HIV-infected patients with highly active antiretroviral therapy-associated metabolic syndrome. Curr HIV Res 2007, 5(2):275-279.
42. Shimabukuro M. Cardiac adiposity and global cardiometabolic risk: new concept and clinical implication. Circ J 2009, 73(1):27-34.
43. Iacobellis G., Willens H.J. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 2009, 22(12):1311-1319. [quiz: 1417-8].
44. Gormez S., Demirkan A., Atalar F., et al. Adipose tissue gene expression of adiponectin, tumor necrosis factor-alpha and leptin in metabolic syndrome patients with coronary artery disease. Intern Med 2011, 50(8):805-810.
45. Vural B., Atalar F., Ciftci C., et al. Presence of fatty-acid-binding protein 4 expression in human epicardial adipose tissue in metabolic syndrome. Cardiovasc Pathol 2008, 17(6):392-398.
46. Kotulak T., Drapalova J., Kopecky P., et al. Increased circulating and epicardial adipose tissue mRNA expression of fibroblast growth factor-21 after cardiac surgery: possible role in postoperative inflammatory response and insulin resistance. Physiol Res 2011, 60(5):757-767.
47. Kremen J., Dolinkova M., Krajickova J., et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006, 91(11):4620-4627.
48. Sade L.E., Eroglu S., Bozbas H., et al. Relation between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries. Atherosclerosis 2009, 204(2):580-585.
49. Aydin H., Toprak A., Deyneli O., et al. Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome. Metab Syndr Relat Disord 2010, 8(3):229-234.
50. Perseghin G., Lattuada G., De Cobelli F., et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology 2008, 47(1):51-58.
51. Sironi A.M., Pingitore A., Ghione S., et al. Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat. Hypertension 2008, 51(2):282-288.
52. Sengul C., Duman D. The association of epicardial fat thickness with blunted heart rate recovery in patients with metabolic syndrome. Tohoku J Exp Med 2011, 224(4):257-262.
53. Lin Y.K., Chen Y.J., Chen S.A. Potential atrial arrhythmogenicity of adipocytes: implications for the genesis of atrial fibrillation. Med Hypotheses 2010, 74(6):1026-1029.